![Natera, Inc. logo](/logos/NTRA.webp)
Natera, Inc.
NASDAQ:NTRA
Overview | Financials
Company Name | Natera, Inc. |
Symbol | NTRA |
Currency | USD |
Price | 112.9 |
Market Cap | 13,963,584,900 |
Dividend Yield | 0% |
52-week-range | 36.9 - 124.83 |
Industry | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Steven Leonard Chapman |
Website | https://www.natera.com |
An error occurred while fetching data.
About Natera, Inc.
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD